-
Sajid Javid combats cancer crisis
pharmatimes
February 04, 2022
UK’s health and social care secretary will declare war on cancer with a decade-long plan to combat disease misery.
-
FLIP sync: Collaboration for inhibitors and cancer treatments
pharmatimes
January 26, 2022
Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments.
-
Know Your Thyroid Facts
drugs
January 10, 2022
Thyroid cancer diagnoses have spiked for U.S. women this past decade.
-
Protecting People with Cancer from COVID-19: New Recommendations from Cancer Guidelines Organization
prnewswire
January 05, 2022
Today, the National Comprehensive Cancer Network? (NCCN?) published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of COVID-19 in people with cancer.
-
New blood test can identify presence of cancer
pharmatimes
January 05, 2022
The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.
-
Five-drug combination for ultra-high-risk bone marrow cancer identified
PharmaTimes
December 14, 2021
A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.
-
50 Years of Progress in Treating Patients with Cancer
FDA
December 13, 2021
By Richard?Pazdur, MD,?Director, Oncology Center of Excellence (OCE)?and Acting Director, Office of Oncologic Diseases (OOD)
-
LianBio Provides Corporate Update and Reports?Third?Quarter 2021 Financial Results
PhamaSources.com
December 10, 2021
LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.
-
Updated NCCN Distress Thermometer and Problem List Helps People Cope with Cancer Symptoms and Treatment
prnasia
December 07, 2021
The National Comprehensive Cancer Network (NCCN?)—a nonprofit alliance of leading cancer centers—announces updates to its widely-used resource for enabling discussion and treatment of distress as part of routine care...
-
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community
WorldPharmaNews
December 02, 2021
GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme will provide education on progress in ...